Patents Assigned to Niche Biopharmaceuticals LLC
  • Patent number: 11873272
    Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: January 16, 2024
    Assignee: Niche Biopharmaceuticals LLC
    Inventors: Dayton T. Reardan, Paul Brennan, Patrick Schlievert
  • Publication number: 20230174473
    Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
    Type: Application
    Filed: January 31, 2023
    Publication date: June 8, 2023
    Applicant: Niche Biopharmaceuticals LLC
    Inventors: Dayton T. Reardan, Paul Brennan, Patrick Schlievert
  • Patent number: 11572342
    Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: February 7, 2023
    Assignee: Niche Biopharmaceuticals LLC
    Inventors: Dayton T. Reardan, Paul Brennan, Patrick Schlievert
  • Patent number: 11365176
    Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: June 21, 2022
    Assignee: Niche Biopharmaceuticals LLC
    Inventors: Dayton T. Reardan, Paul Brennan, Patrick Schlievert